Showing results (951-960 of 7,009) with videos related to
Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|November 27, 2009
Skeletal morbidity in lung cancer patients with bone metastases: demonstrating the need for early diagnosis and treatment with bisphosphonatesCorey Langer, Vera HirshLung Cancer (Amsterdam, Netherlands)|November 10, 2009
Chronic exposure to estrogen and the tobacco carcinogen NNK cooperatively modulates nicotinic receptors in small airway epithelial cellsHussein A N Al-Wadei, Mohammed H Al-Wadei, Thomas Masi, et al.Lung Cancer (Amsterdam, Netherlands)|November 3, 2009
Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trialNicolas Girard, Françoise Mornex, Jean-Yves Douillard, et al.Lung Cancer (Amsterdam, Netherlands)|November 3, 2009
Well-differentiated papillary mesothelioma with invasion to the chest wallIkuko Torii, Masaki Hashimoto, Takayuki Terada, et al.Lung Cancer (Amsterdam, Netherlands)|September 27, 2014
MEK inhibition in non-small cell lung cancerThomas E Stinchcombe, Gary L JohnsonLung Cancer (Amsterdam, Netherlands)|September 28, 2014
A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC)Xingsheng Hu, Baohui Han, Aiqin Gu, et al.Lung Cancer (Amsterdam, Netherlands)|December 10, 2014
Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?Yong Won Choi, Mi Sun Ahn, Geum Sook Jeong, et al.Lung Cancer (Amsterdam, Netherlands)|December 10, 2014
Alterations of a spectrum of driver genes in female Chinese patients with advanced or metastatic squamous cell carcinoma of the lungZhao Qiong, Wang Yi Na, Wang Bo, et al.Lung Cancer (Amsterdam, Netherlands)|December 16, 2014
Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: a retrospective analysis in KoreaJin Ho Baek, Jong-Mu Sun, Young Joo Min, et al.Lung Cancer (Amsterdam, Netherlands)|September 14, 2014
Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trialsAaron S Mansfield, James T Symanowski, Tobias PeikertPageof 701